Fairtree Asset Management’s ResMed RMD Stock Holding History

Fairtree Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.37M	Buy	10,548 +2,128	+25%	+$530K	1.09%	23
2025 Q4	$2.03M	Buy	8,420 +4,389	+109%	+$1.12M	0.93%	30
2025 Q3	$1.1M	Buy	4,031 +1,222	+44%	+$334K	0.72%	42
2025 Q2	$725K	Hold	2,809	–	–	0.55%	58
2025 Q1	$629K	Buy	+2,809	New	+$656K	0.51%	54

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fairtree Asset Management's RMD Position: Q1 2026 in Review

Fairtree Asset Management increased its ResMed (RMD) stake by 25% in Q1 2026, buying an estimated $530K and bringing the position to 10,548 shares worth $2.37M. The position accounts for 1.09% of the portfolio, ranked #23.

Fairtree Asset Management first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Fairtree Asset Management held 10,548 shares of ResMed worth $2.37M as of Q1 2026.
Fairtree Asset Management bought 2,128 ResMed shares in Q1 2026, an estimated $530K.
ResMed made up 1.09% of Fairtree Asset Management's portfolio in Q1 2026, its #23 holding.
Fairtree Asset Management first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Fairtree Asset Management's 13F filing for Q1 2026, filed 13 May 2026.